MethylGene Inc. of MONTREAL, A8, a company, filed a Form D amendment with the SEC on 2012-09-11. The offering totals $48.3M, of which $35.6M was reported sold. Industry: Biotechnology.
Showing 25 of 34 people.
| Name | Role | Location |
|---|---|---|
| HENRY J. FUCHS | Director | MONTREAL, A8 |
| CHARLES R. GRUBSZTAJN | Director | MONTREAL, A8 |
| LOUIS W. LACASSE | Director | MONTREAL, A8 |
| RODNEY W. LAPPE | Director | MONTREAL, A8 |
| COLIN R. MALLET | Director | MONTREAL, A8 |
| PEGGY R. MULLIGAN | Director | MONTREAL, A8 |
| PETER B. THOMPSON | Director | Montreal, A8 |
| JEFFREY M. BESTERMAN | Executive Officer | MONTREAL, A8 |
| CHARLES R. GRUBSZTAJN | Executive Officer | MONTREAL, A8 |
| RACHEL B. HUMPHREY | Executive Officer | Montreal, A8 |
| KLAUS B. KEPPER | Executive Officer | MONTREAL, A8 |
| GREGORY B. REID | Executive Officer | Montreal, A8 |
| ARKADIL B. VAISBURG | Executive Officer | Montreal, A8 |
| JOSEPH B. WALEWICZ | Executive Officer | Montreal, A8 |
| GREGORY B REID | Executive Officer | Montreal, A8 |
| HENRY J FUCHS | Director | MONTREAL, A8 |
| KLAUS B KEPPER | Executive Officer | MONTREAL, A8 |
| RACHEL B HUMPHREY | Executive Officer | Montreal, A8 |
| RODNEY W LAPPE | Director | MONTREAL, A8 |
| PETER W THOMPSON | Director | MONTREAL, A8 |
| JOSEPH B WALEWICZ | Executive Officer | Montreal, A8 |
| JEFFREY M BESTERMAN | Executive Officer | MONTREAL, A8 |
| PEGGY W MULLIGAN | Director | MONTREAL, A8 |
| MARTIN GODBOUT | Director | MONTREAL, A8 |
| MARTIN GODBOUT | Executive Officer | MONTREAL, A8 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2012-11-21 | D | $35.5M | $26.1M |
| 2012-11-16 | D/A | $48.3M | $35.6M |
| 2011-04-07 | D | $48.3M | $35.5M |